K. Kubota et al., MEASUREMENT OF LIVER VOLUME AND HEPATIC FUNCTIONAL RESERVE AS A GUIDETO DECISION-MAKING IN RESECTIONAL SURGERY FOR HEPATIC-TUMORS, Hepatology, 26(5), 1997, pp. 1176-1181
The respective volumes of hepatic tumors and nontumorous parenchyma of
SO patients requiring hepatectomy of more than one segment of Healey
for tumor removal were measured using computed tomography (Vol-CT). Th
e volume estimated by Vol-CT was found to correlate with the real weig
ht resected (P < .0001) with a mean absolute error of 64.9 mt. The rat
io of the nontumorous parenchymal volume of the resected liver to that
of the whole liver (R2) in 15 patients who underwent right or extende
d right hepatic lobectomy was 43% +/- 15%. Eight of 15 patients with R
2s < 60% underwent the procedures without right portal vein embolizati
on (PE). The other seven with R2s exceeding 60% or an indocyanine gree
n retention rate after 15 minutes (ICG15) of 10% to 20% underwent PE:
in six of seven, the nontumorous parenchyma of the right hepatic lobe
became atrophic and in all seven, the volume of the remaining left hep
atic lobe increased with a decrease in the mean R2 from 62% +/- 14% to
55% +/- 8% (P = .0006). In the remaining 35 who underwent other hepat
ectomy procedures, R2s also remained < 60%. Overall, at surgery, in 27
with normal liver function (ICG15 < 10%), R2s exceeded 60% in one, re
mained at 50% to 60% in five, and < 50% in 21, whereas 23 patients exc
ept for one with an ICG15 exceeding 10%, had R2s of < 50%. The postope
rative serum total bilirubin levels in 84% of the patients remained wi
thin the normal range and there was no surgery-related mortality. In c
onclusion, 1) Vol-CT can accurately assess the extent of liver resecti
on, 2) individuals with normal liver function can undergo resection of
up to 60% of the nontumorous parenchyma without the need for PE, and
3) PE can be used to reduce the size of the resected tissue and increa
se the volume of the remnant liver to approximate the target limits in
individuals with large tumors or minimally abnormal liver function.